Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany
Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany
This investigation is designed to evaluate the performance, comfort and ease of use of the
 Simplus and Eson masks amongst NIV patients who are currently on Bi-level therapy
Up to 40 NIV patients who currently use a full face mask or a nasal mask will be recruited.
 They will be issued a Simplus (if they are existing full face users) or Eson (if they are
 existing nasal users) to use in-home for 2 weeks. This will consists of male and female
 participants who have been prescribed with NIV therapy for at least 3 months.
Inclusion Criteria:

 -  Aged 18+

 -  Existing full face mask user or a nasal mask user

 -  Prescribed NIV therapy for at least 3 months

 Exclusion Criteria:

 -  Inability to give informed consent

 -  Pregnant or think they may be pregnant

 -  Anatomical or physiological conditions making NIVtherapy inappropriate

 -  Patients who are in a coma or decreased level of consciousness

 -  Existing Simplus and Eson users